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In the 1990s, genetically modified (GM) crops have rapidly gained favor with farmers 
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and increased in market share. GM crops are different from natural ones in that they are 
manufactured, not plants naturally grown. This aspect is very significant when we 
discuss the patentability of GM crops. The multinationals developing GM seeds have 
claimed patent protection for their “inventions” and the governments in the USA and 
Canada have concluded that GM crops are not the “discovery” of genes resulting from a 
law of nature. In other words, GM crops can be patentable as long as they can be 
approved as inventions with novelty and usefulness. 
   In the meantime, the multinationals require the farmers who purchase the 
patented GM seeds to sign the Technology Use Agreement (TUA) under which the 
farmers are not allowed to save, replant, transfer and sell them. However, the “farmers’ 
privilege” provided in the UPOV conventions has traditionally granted the farmers the 
right to save, replant, transfer and sell the seeds obtained from their own property. 
 The main focus of this paper is on the conflict over the patentability of GMOs 
in terms of the protection of farmers’ privilege. This paper considers the fact that the 
multinationals’ TUA restrict farmers’ privilege by referring to the first lawsuit in which 
Monsanto Co. sued Mr. Schmeiser, a Canadian farmer, against the patent rights for GM 
canola. In this lawsuit, Monsanto claimed that Mr. Schmeiser illegally saved and sold 
the GM canola seeds without signing the TUA with Monsanto, although Mr. Schmeiser 
claimed that the GM canola he used were grown naturally on his holdings because of 
wind or pollination. The conclusion is that the multinationals will restrict framers’ 
privilege and strengthen their control over the property rights for genetic resources by 
making use of patent protection and its resulting TUA. Thus, this paper stresses that the 
soundness of life patent should be discussed based not only on ethical aspects, but on 
the structure of resource allocation between the multinationals and farmers. 
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はじめに 
 




















































































このチャクラバーティ・ダイヤモンド判決は 5 対 4 という僅差でチャクラバ
ーティ氏に対し特許権を認める結果となったが、生命特許を認める判決に反対
した４人の判事の意見も公開されている2。その中で特に注目されるのが、特許

































































１．３ WTOの TRIPs 
 
世界貿易機関(WTO)の「知的所有権の貿易関連側面に関する協定(TRIPs)」7は











































































































































































































（ｃ）TUA に違反して RR の遺伝子を含む種子を販売、譲渡、運搬した場合に
は、それらの行為のためにＲＲカノーラを栽培した土地について、1エー
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らに、米モンサント社は、シュマイザー氏が得た収益を 10 万 5000 ドルと決定
した。米モンサント社と加モンサント社が個別に損害額を決定できない場合に





性であることを知りながらも、貯蔵した種子を用いて、1998 年に 9 箇所の畑に
おいてＲＲカノーラを栽培し、そのカノーラを収穫・販売したことは、原告が




































































































































































































社側の管理責任は問われなかった。例えば、除草剤 RR に耐性をもつ GM 作物
の種子がそれを栽培していない農家の土地に何らかの経路で自生した場合、そ
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